Effects of oxcarbazepine on cognitive function in children and adolescents with partial seizures

F. Donati, G. Gobbi, J. Campistol, G. Rapatz, M. Daehler, Y. Sturm, A. P. Aldenkamp

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

The authors investigated the effect of oxcarbazepine on cognitive function in children and adolescents (6 to younger than 17 years of age) with newly diagnosed partial seizures in an open-label comparison with standard antiepileptic drug therapy (carbamazepine and valproate). No differences in cognitive tests were observed between oxcarbazepine and carbamazepine/valproate over a 6-month treatment period.

Original languageEnglish
Pages (from-to)679-682
Number of pages4
JournalNeurology
Volume67
Issue number4
DOIs
Publication statusPublished - Aug 2006

Fingerprint

Carbamazepine
Valproic Acid
Cognition
Seizures
Anticonvulsants
Drug Therapy
oxcarbazepine
Therapeutics

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Donati, F., Gobbi, G., Campistol, J., Rapatz, G., Daehler, M., Sturm, Y., & Aldenkamp, A. P. (2006). Effects of oxcarbazepine on cognitive function in children and adolescents with partial seizures. Neurology, 67(4), 679-682. https://doi.org/10.1212/01.wnl.0000230138.46508.5b

Effects of oxcarbazepine on cognitive function in children and adolescents with partial seizures. / Donati, F.; Gobbi, G.; Campistol, J.; Rapatz, G.; Daehler, M.; Sturm, Y.; Aldenkamp, A. P.

In: Neurology, Vol. 67, No. 4, 08.2006, p. 679-682.

Research output: Contribution to journalArticle

Donati, F, Gobbi, G, Campistol, J, Rapatz, G, Daehler, M, Sturm, Y & Aldenkamp, AP 2006, 'Effects of oxcarbazepine on cognitive function in children and adolescents with partial seizures', Neurology, vol. 67, no. 4, pp. 679-682. https://doi.org/10.1212/01.wnl.0000230138.46508.5b
Donati, F. ; Gobbi, G. ; Campistol, J. ; Rapatz, G. ; Daehler, M. ; Sturm, Y. ; Aldenkamp, A. P. / Effects of oxcarbazepine on cognitive function in children and adolescents with partial seizures. In: Neurology. 2006 ; Vol. 67, No. 4. pp. 679-682.
@article{37be7bc4b26848bbbfae27a21064484a,
title = "Effects of oxcarbazepine on cognitive function in children and adolescents with partial seizures",
abstract = "The authors investigated the effect of oxcarbazepine on cognitive function in children and adolescents (6 to younger than 17 years of age) with newly diagnosed partial seizures in an open-label comparison with standard antiepileptic drug therapy (carbamazepine and valproate). No differences in cognitive tests were observed between oxcarbazepine and carbamazepine/valproate over a 6-month treatment period.",
author = "F. Donati and G. Gobbi and J. Campistol and G. Rapatz and M. Daehler and Y. Sturm and Aldenkamp, {A. P.}",
year = "2006",
month = "8",
doi = "10.1212/01.wnl.0000230138.46508.5b",
language = "English",
volume = "67",
pages = "679--682",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Effects of oxcarbazepine on cognitive function in children and adolescents with partial seizures

AU - Donati, F.

AU - Gobbi, G.

AU - Campistol, J.

AU - Rapatz, G.

AU - Daehler, M.

AU - Sturm, Y.

AU - Aldenkamp, A. P.

PY - 2006/8

Y1 - 2006/8

N2 - The authors investigated the effect of oxcarbazepine on cognitive function in children and adolescents (6 to younger than 17 years of age) with newly diagnosed partial seizures in an open-label comparison with standard antiepileptic drug therapy (carbamazepine and valproate). No differences in cognitive tests were observed between oxcarbazepine and carbamazepine/valproate over a 6-month treatment period.

AB - The authors investigated the effect of oxcarbazepine on cognitive function in children and adolescents (6 to younger than 17 years of age) with newly diagnosed partial seizures in an open-label comparison with standard antiepileptic drug therapy (carbamazepine and valproate). No differences in cognitive tests were observed between oxcarbazepine and carbamazepine/valproate over a 6-month treatment period.

UR - http://www.scopus.com/inward/record.url?scp=33747661652&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33747661652&partnerID=8YFLogxK

U2 - 10.1212/01.wnl.0000230138.46508.5b

DO - 10.1212/01.wnl.0000230138.46508.5b

M3 - Article

C2 - 16924022

AN - SCOPUS:33747661652

VL - 67

SP - 679

EP - 682

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 4

ER -